News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
《業績》恒瑞醫藥(01276.HK)首季歸屬股東淨利潤按年上升21.78%
恒瑞醫藥(01276.HK)公布，今年首季營業收入按年上升12.98%至81.41億元人民幣(下同)，歸屬於上市公司股東的淨利潤按年上升21.78%至22.82億元。以扣除非經常性損益計算，歸屬於上市公司股東的淨利潤按年增長16.59%至21.72億元。基本每股收益0.34元。(ss/a)~阿思達克財經新聞網址: www.aastocks.com
Reset
Send
The window will close in 5 seconds
《業績》恒瑞醫藥(01276.HK)首季歸屬股東淨利潤按年上升21.78%
Close
Recommend
12
Positive
13
Negative
4
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get 1 Intel/Gold ETF share!

恒瑞醫藥(01276.HK)  -0.650 (-0.979%)    Short selling $66.91M; Ratio 27.140%   公布，今年首季營業收入按年上升12.98%至81.41億元人民幣(下同)，歸屬於上市公司股東的淨利潤按年上升21.78%至22.82億元。以扣除非經常性損益計算，歸屬於上市公司股東的淨利潤按年增長16.59%至21.72億元。基本每股收益0.34元。(ss/a)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-15 16:25.)

Dividend History
Announce DateEventParticular
2026/03/26FinalD:RMB 0.2000 (Equivalent to approximately HKD 0.22828)
2025/10/273rd QuarterlyNo Dividend
2025/08/20InterimNo Dividend

Switch to Auto-Translated Version
AASTOCKS新聞
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.